2023 Q3 Form 10-Q Financial Statement

#000143710723000144 Filed on August 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $9.979B $10.36B
YoY Change 1.59% 5.4%
Cost Of Revenue $5.118B $6.608B
YoY Change -9.05% -0.26%
Gross Profit $4.861B $3.750B
YoY Change 15.85% 17.11%
Gross Profit Margin 48.71% 36.2%
Selling, General & Admin $2.291B $2.562B
YoY Change -11.51% -27.59%
% of Gross Profit 47.13% 68.32%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.984B $6.524B
YoY Change -19.27% -11.62%
% of Gross Profit 102.53% 173.97%
Operating Expenses $2.291B $4.476B
YoY Change -11.51% 26.51%
Operating Profit $97.00M -$726.0M
YoY Change -104.43% -80.05%
Interest Expense $574.0M -$611.0M
YoY Change 3.42% -219.57%
% of Operating Profit 591.75%
Other Income/Expense, Net -$63.00M $42.00M
YoY Change 125.0% -182.35%
Pretax Income -$532.0M -$1.480B
YoY Change -81.34% -65.13%
Income Tax -$125.0M -$260.0M
% Of Pretax Income
Net Earnings -$417.0M -$1.240B
YoY Change -81.93% -63.72%
Net Earnings / Revenue -4.18% -11.97%
Basic Earnings Per Share -$0.17 -$0.51
Diluted Earnings Per Share -$0.17 -$0.51
COMMON SHARES
Basic Shares Outstanding 2.437B shares 2.436B shares
Diluted Shares Outstanding 2.438B shares 2.437B shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.383B $3.027B
YoY Change -1.61% 17.55%
Cash & Equivalents $2.383B $3.027B
Short-Term Investments
Other Short-Term Assets $4.136B $3.976B
YoY Change 80.38% -31.74%
Inventory
Prepaid Expenses
Receivables $6.312B $6.770B
Other Receivables $0.00 $0.00
Total Short-Term Assets $12.83B $13.77B
YoY Change 1.25% -10.85%
LONG-TERM ASSETS
Property, Plant & Equipment $5.810B $5.473B
YoY Change -30.54% -2.22%
Goodwill $34.73B $34.91B
YoY Change 0.8% 1.86%
Intangibles $39.87B $41.58B
YoY Change -14.7% -14.65%
Long-Term Investments $971.0M $1.009B
YoY Change
Other Assets $8.053B $8.484B
YoY Change -7.99% 5.04%
Total Long-Term Assets $110.9B $114.8B
YoY Change -10.1% -9.42%
TOTAL ASSETS
Total Short-Term Assets $12.83B $13.77B
Total Long-Term Assets $110.9B $114.8B
Total Assets $123.7B $128.6B
YoY Change -9.04% -9.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.329B $1.689B
YoY Change -13.36% 20.9%
Accrued Expenses $10.04B $10.67B
YoY Change -1.54% 3.78%
Deferred Revenue $1.917B $1.548B
YoY Change 13.57% -6.92%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.302B $3.001B
YoY Change 3.58% 173.56%
Total Short-Term Liabilities $14.59B $16.91B
YoY Change -0.6% 17.11%
LONG-TERM LIABILITIES
Long-Term Debt $43.50B $44.28B
YoY Change -10.86% -13.84%
Other Long-Term Liabilities $10.42B $10.93B
YoY Change 0.57% 11.53%
Total Long-Term Liabilities $10.42B $55.21B
YoY Change 0.57% 463.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.59B $16.91B
Total Long-Term Liabilities $10.42B $55.21B
Total Liabilities $77.61B $83.17B
YoY Change -9.73% -6.86%
SHAREHOLDERS EQUITY
Retained Earnings -$526.0M -$105.0M
YoY Change -112.22% -101.59%
Common Stock $27.00M $27.00M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $44.77B $45.45B
YoY Change
Total Liabilities & Shareholders Equity $123.7B $128.6B
YoY Change -9.04% -9.58%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$417.0M -$1.240B
YoY Change -81.93% -63.72%
Depreciation, Depletion And Amortization $4.984B $6.524B
YoY Change -19.27% -11.62%
Cash From Operating Activities $2.516B $2.014B
YoY Change 1929.03% 99.21%
INVESTING ACTIVITIES
Capital Expenditures $457.0M $292.0M
YoY Change -244.62% -231.53%
Acquisitions
YoY Change
Other Investing Activities -$1.000M -$18.00M
YoY Change -100.08% -100.7%
Cash From Investing Activities -$458.0M -$310.0M
YoY Change -153.13% -113.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.625B -1.251B
YoY Change 13.49% -64.96%
NET CHANGE
Cash From Operating Activities 2.516B 2.014B
Cash From Investing Activities -458.0M -310.0M
Cash From Financing Activities -2.625B -1.251B
Net Change In Cash -567.0M 453.0M
YoY Change -57.27% -317.79%
FREE CASH FLOW
Cash From Operating Activities $2.516B $2.014B
Capital Expenditures $457.0M $292.0M
Free Cash Flow $2.059B $1.722B
YoY Change 367.95% 39.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
13033000000 usd
CY2022Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
472000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-117000000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
53000000 usd
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
38000000 usd
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
192000000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
19000000 usd
CY2022Q1 disca Temporary Equity Adjustment To Redemption Value
TemporaryEquityAdjustmentToRedemptionValue
3000000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
13227000000 usd
CY2022Q2 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-3411000000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-506000000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
143000000 usd
CY2022Q2 disca Stock And Noncontrolling Interest Issued And Converted During The Period Value Acquisitions
StockAndNoncontrollingInterestIssuedAndConvertedDuringThePeriodValueAcquisitions
43195000000 usd
CY2022Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
31000000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000000 usd
CY2022Q2 disca Temporary Equity Adjustment To Redemption Value
TemporaryEquityAdjustmentToRedemptionValue
1000000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
52619000000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results may differ from these estimates.</span></div>
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-1220000000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-3408000000 usd
us-gaap Profit Loss
ProfitLoss
-2280000000 usd
us-gaap Profit Loss
ProfitLoss
-2933000000 usd
CY2023Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
CY2022Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
49000000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
16000000 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
7000000 usd
us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
24000000 usd
us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
23000000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
4000000 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
3000000 usd
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
5000000 usd
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
6000000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1240000000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3418000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2309000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3011000000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2437000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2437000000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2286000000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2286000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2434000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2434000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1443000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1443000000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.51
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.50
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.95
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.09
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.51
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.50
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.95
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.09
CY2022Q2 disca Entertainment Number Of Countries And Territories Available
EntertainmentNumberOfCountriesAndTerritoriesAvailable
220 countryandterritory
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
44989000000 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
146000000 usd
CY2022Q2 us-gaap Restructuring Charges
RestructuringCharges
1033000000 usd
us-gaap Restructuring Charges
RestructuringCharges
241000000 usd
us-gaap Restructuring Charges
RestructuringCharges
1038000000 usd
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
864000000 usd
us-gaap Restructuring Reserve Translation And Other Adjustment
RestructuringReserveTranslationAndOtherAdjustment
2000000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
580000000 usd
CY2023Q2 us-gaap Restructuring Reserve
RestructuringReserve
472000000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10358000000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9827000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21058000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12986000000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1548000000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1694000000 usd
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
393000000 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
361000000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1102000000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
347000000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
13216000000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
13216000000 usd
CY2023Q2 us-gaap Gain Loss On Securitization Of Financial Assets
GainLossOnSecuritizationOfFinancialAssets
-9000000 usd
us-gaap Gain Loss On Securitization Of Financial Assets
GainLossOnSecuritizationOfFinancialAssets
-42000000 usd
CY2022Q2 us-gaap Gain Loss On Securitization Of Financial Assets
GainLossOnSecuritizationOfFinancialAssets
-41000000 usd
us-gaap Gain Loss On Securitization Of Financial Assets
GainLossOnSecuritizationOfFinancialAssets
-41000000 usd
CY2023Q2 us-gaap Derecognized Assets Securitized Or Assetbacked Financing Arrangement Assets And Any Other Financial Assets Managed Together Principal Amount Outstanding
DerecognizedAssetsSecuritizedOrAssetbackedFinancingArrangementAssetsAndAnyOtherFinancialAssetsManagedTogetherPrincipalAmountOutstanding
5295000000 usd
CY2023Q2 us-gaap Cash Flows Between Transferee And Transferor Proceeds From New Transfers
CashFlowsBetweenTransfereeAndTransferorProceedsFromNewTransfers
3637000000 usd
CY2022Q2 us-gaap Cash Flows Between Transferee And Transferor Proceeds From New Transfers
CashFlowsBetweenTransfereeAndTransferorProceedsFromNewTransfers
3205000000 usd
us-gaap Cash Flows Between Transferee And Transferor Proceeds From New Transfers
CashFlowsBetweenTransfereeAndTransferorProceedsFromNewTransfers
6416000000 usd
us-gaap Cash Flows Between Transferee And Transferor Proceeds From New Transfers
CashFlowsBetweenTransfereeAndTransferorProceedsFromNewTransfers
3205000000 usd
CY2023Q2 us-gaap Cash Flows Between Transferee And Transferor Purchases Of Previously Transferred Financial Assets
CashFlowsBetweenTransfereeAndTransferorPurchasesOfPreviouslyTransferredFinancialAssets
3642000000 usd
CY2022Q2 us-gaap Cash Flows Between Transferee And Transferor Purchases Of Previously Transferred Financial Assets
CashFlowsBetweenTransfereeAndTransferorPurchasesOfPreviouslyTransferredFinancialAssets
3505000000 usd
us-gaap Cash Flows Between Transferee And Transferor Purchases Of Previously Transferred Financial Assets
CashFlowsBetweenTransfereeAndTransferorPurchasesOfPreviouslyTransferredFinancialAssets
6487000000 usd
us-gaap Cash Flows Between Transferee And Transferor Purchases Of Previously Transferred Financial Assets
CashFlowsBetweenTransfereeAndTransferorPurchasesOfPreviouslyTransferredFinancialAssets
3505000000 usd
CY2023Q2 disca Cash Flows Between Transferor And Transferee Net Cash Proceeds Received Collections Reinvested
CashFlowsBetweenTransferorAndTransfereeNetCashProceedsReceivedCollectionsReinvested
-5000000 usd
CY2022Q2 disca Cash Flows Between Transferor And Transferee Net Cash Proceeds Received Collections Reinvested
CashFlowsBetweenTransferorAndTransfereeNetCashProceedsReceivedCollectionsReinvested
-300000000 usd
disca Cash Flows Between Transferor And Transferee Net Cash Proceeds Received Collections Reinvested
CashFlowsBetweenTransferorAndTransfereeNetCashProceedsReceivedCollectionsReinvested
-71000000 usd
disca Cash Flows Between Transferor And Transferee Net Cash Proceeds Received Collections Reinvested
CashFlowsBetweenTransferorAndTransfereeNetCashProceedsReceivedCollectionsReinvested
-300000000 usd
CY2023Q2 disca Financial Assets Sold Under Agreements To Repurchase Gross Including Not Subject To Master Netting Arrangement Net Receivables Sold
FinancialAssetsSoldUnderAgreementsToRepurchaseGrossIncludingNotSubjectToMasterNettingArrangementNetReceivablesSold
3606000000 usd
CY2022Q2 disca Financial Assets Sold Under Agreements To Repurchase Gross Including Not Subject To Master Netting Arrangement Net Receivables Sold
FinancialAssetsSoldUnderAgreementsToRepurchaseGrossIncludingNotSubjectToMasterNettingArrangementNetReceivablesSold
3198000000 usd
disca Financial Assets Sold Under Agreements To Repurchase Gross Including Not Subject To Master Netting Arrangement Net Receivables Sold
FinancialAssetsSoldUnderAgreementsToRepurchaseGrossIncludingNotSubjectToMasterNettingArrangementNetReceivablesSold
6304000000 usd
disca Financial Assets Sold Under Agreements To Repurchase Gross Including Not Subject To Master Netting Arrangement Net Receivables Sold
FinancialAssetsSoldUnderAgreementsToRepurchaseGrossIncludingNotSubjectToMasterNettingArrangementNetReceivablesSold
3198000000 usd
CY2023Q2 disca Transfers Of Financial Assets Accounted For As Sale Initial Fair Value Of Liabilities Incurred Obligations Recorded
TransfersOfFinancialAssetsAccountedForAsSaleInitialFairValueOfLiabilitiesIncurredObligationsRecorded
112000000 usd
CY2022Q2 disca Transfers Of Financial Assets Accounted For As Sale Initial Fair Value Of Liabilities Incurred Obligations Recorded
TransfersOfFinancialAssetsAccountedForAsSaleInitialFairValueOfLiabilitiesIncurredObligationsRecorded
98000000 usd
disca Transfers Of Financial Assets Accounted For As Sale Initial Fair Value Of Liabilities Incurred Obligations Recorded
TransfersOfFinancialAssetsAccountedForAsSaleInitialFairValueOfLiabilitiesIncurredObligationsRecorded
260000000 usd
disca Transfers Of Financial Assets Accounted For As Sale Initial Fair Value Of Liabilities Incurred Obligations Recorded
TransfersOfFinancialAssetsAccountedForAsSaleInitialFairValueOfLiabilitiesIncurredObligationsRecorded
98000000 usd
CY2023Q2 disca Cash Flows Between Transferor And Transferee Net Cash Proceeds Received Not Remitted
CashFlowsBetweenTransferorAndTransfereeNetCashProceedsReceivedNotRemitted
405000000 usd
disca Transfer And Servicing Of Financial Assets Accounted For As Sales Accounts Receivables Sold
TransferAndServicingOfFinancialAssetsAccountedForAsSalesAccountsReceivablesSold
72000000 usd
disca Transfer And Servicing Of Financial Assets Accounted For As Sales Accounts Receivables Sold
TransferAndServicingOfFinancialAssetsAccountedForAsSalesAccountsReceivablesSold
0 usd
CY2023Q2 us-gaap Film Monetized On Its Own Capitalized Cost
FilmMonetizedOnItsOwnCapitalizedCost
7920000000 usd
CY2023Q2 us-gaap Film Monetized In Film Group Capitalized Cost
FilmMonetizedInFilmGroupCapitalizedCost
11014000000 usd
CY2023Q2 us-gaap Film Costs
FilmCosts
18934000000 usd
CY2023Q2 disca Film Programming Rights After Amortization
FilmProgrammingRightsAfterAmortization
5295000000 usd
CY2023Q2 disca Content Game Development Costs After Amortization
ContentGameDevelopmentCostsAfterAmortization
604000000 usd
CY2023Q2 disca Content Rights Net
ContentRightsNet
24833000000 usd
CY2023Q2 disca Content Rights And Prepaid License Fees Net Current
ContentRightsAndPrepaidLicenseFeesNetCurrent
440000000 usd
CY2023Q2 disca Content Library Net Noncurrent
ContentLibraryNetNoncurrent
24393000000 usd
CY2022Q4 us-gaap Film Monetized On Its Own Capitalized Cost
FilmMonetizedOnItsOwnCapitalizedCost
9442000000 usd
CY2022Q4 us-gaap Film Monetized In Film Group Capitalized Cost
FilmMonetizedInFilmGroupCapitalizedCost
11262000000 usd
CY2022Q4 us-gaap Film Costs
FilmCosts
20704000000 usd
CY2022Q4 disca Film Programming Rights After Amortization
FilmProgrammingRightsAfterAmortization
5843000000 usd
CY2022Q4 disca Content Game Development Costs After Amortization
ContentGameDevelopmentCostsAfterAmortization
650000000 usd
CY2022Q4 disca Content Rights Net
ContentRightsNet
27197000000 usd
CY2022Q4 disca Content Rights And Prepaid License Fees Net Current
ContentRightsAndPrepaidLicenseFeesNetCurrent
545000000 usd
CY2022Q4 disca Content Library Net Noncurrent
ContentLibraryNetNoncurrent
26652000000 usd
CY2023Q2 us-gaap Film Monetized On Its Own Amortization Expense
FilmMonetizedOnItsOwnAmortizationExpense
1031000000 usd
CY2022Q2 us-gaap Film Monetized On Its Own Amortization Expense
FilmMonetizedOnItsOwnAmortizationExpense
1927000000 usd
us-gaap Film Monetized On Its Own Amortization Expense
FilmMonetizedOnItsOwnAmortizationExpense
2562000000 usd
us-gaap Film Monetized On Its Own Amortization Expense
FilmMonetizedOnItsOwnAmortizationExpense
2177000000 usd
CY2023Q2 us-gaap Film Monetized In Film Group Amortization Expense
FilmMonetizedInFilmGroupAmortizationExpense
3579000000 usd
CY2022Q2 us-gaap Film Monetized In Film Group Amortization Expense
FilmMonetizedInFilmGroupAmortizationExpense
3189000000 usd
us-gaap Film Monetized In Film Group Amortization Expense
FilmMonetizedInFilmGroupAmortizationExpense
6675000000 usd
us-gaap Film Monetized In Film Group Amortization Expense
FilmMonetizedInFilmGroupAmortizationExpense
3908000000 usd
CY2023Q2 disca Film Monetized On Its Own And Film Group Content Expense
FilmMonetizedOnItsOwnAndFilmGroupContentExpense
4610000000 usd
CY2022Q2 disca Film Monetized On Its Own And Film Group Content Expense
FilmMonetizedOnItsOwnAndFilmGroupContentExpense
5116000000 usd
disca Film Monetized On Its Own And Film Group Content Expense
FilmMonetizedOnItsOwnAndFilmGroupContentExpense
9237000000 usd
disca Film Monetized On Its Own And Film Group Content Expense
FilmMonetizedOnItsOwnAndFilmGroupContentExpense
6085000000 usd
CY2023Q2 us-gaap Equity Method Investments
EquityMethodInvestments
1009000000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
1062000000 usd
CY2023Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
43000000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
28000000 usd
CY2023Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
436000000 usd
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
498000000 usd
CY2023Q2 us-gaap Investments
Investments
1488000000 usd
CY2022Q4 us-gaap Investments
Investments
1588000000 usd
CY2023Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
3000000 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
71000000 usd
CY2023Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount
300000000 usd
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
47564000000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
49276000000 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
287000000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
277000000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
47277000000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
48999000000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
3001000000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
365000000 usd
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
44276000000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
48634000000 usd
CY2023Q2 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
0 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
0 usd
CY2023Q2 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
11000000 usd
CY2022Q2 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
0 usd
us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
-1000000 usd
us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
0 usd
CY2023Q2 us-gaap Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1
ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
-11000000 usd
CY2022Q2 us-gaap Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1
ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
0 usd
us-gaap Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1
ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
1000000 usd
us-gaap Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1
ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
0 usd
CY2023Q2 us-gaap Gain Loss On Fair Value Hedges Recognized In Earnings
GainLossOnFairValueHedgesRecognizedInEarnings
0 usd
CY2022Q2 us-gaap Gain Loss On Fair Value Hedges Recognized In Earnings
GainLossOnFairValueHedgesRecognizedInEarnings
0 usd
us-gaap Gain Loss On Fair Value Hedges Recognized In Earnings
GainLossOnFairValueHedgesRecognizedInEarnings
0 usd
us-gaap Gain Loss On Fair Value Hedges Recognized In Earnings
GainLossOnFairValueHedgesRecognizedInEarnings
0 usd
CY2023Q2 us-gaap Gain Loss From Components Excluded From Assessment Of Fair Value Hedge Effectiveness Net
GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet
-20000000 usd
us-gaap Gain Loss From Components Excluded From Assessment Of Fair Value Hedge Effectiveness Net
GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet
-25000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3930000000 usd
CY2023Q2 us-gaap Supplier Finance Program Obligation Current
SupplierFinanceProgramObligationCurrent
270000000 usd
CY2022Q4 us-gaap Supplier Finance Program Obligation Current
SupplierFinanceProgramObligationCurrent
273000000 usd
CY2023Q2 disca Supplier Finance Program Termination Timing Period
SupplierFinanceProgramTerminationTimingPeriod
P30D
CY2022Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-495000000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
875000000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-260000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-438000000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-836000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-635000000 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2134000000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1929000000 usd
us-gaap Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
69000000 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
507000000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
413000000 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-4000000 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-81000000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-97000000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-70000000 usd
CY2023Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
0 usd
CY2022Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-24000000 usd
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
3000000 usd
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
473000000 usd
CY2023Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-8000000 usd
CY2022Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-70000000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
21000000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-90000000 usd
CY2023Q2 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
0 usd
CY2022Q2 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
133000000 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
0 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
133000000 usd
CY2023Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
3000000 usd
CY2022Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
0 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
71000000 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
0 usd
CY2023Q2 disca Other Income Expense Nonoperating Net
OtherIncomeExpenseNonoperatingNet
42000000 usd
CY2022Q2 disca Other Income Expense Nonoperating Net
OtherIncomeExpenseNonoperatingNet
-9000000 usd
disca Other Income Expense Nonoperating Net
OtherIncomeExpenseNonoperatingNet
98000000 usd
disca Other Income Expense Nonoperating Net
OtherIncomeExpenseNonoperatingNet
-7000000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
27000000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-51000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-46000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
439000000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
830000000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
442000000 usd
us-gaap Interest Paid
InterestPaid
1137000000 usd
us-gaap Interest Paid
InterestPaid
390000000 usd
us-gaap Stock Issued1
StockIssued1
0 usd
us-gaap Stock Issued1
StockIssued1
42309000000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
72000000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
47000000 usd
disca Right Of Use Asset Obtained In Exchange For Finance Lease Liabilities And Other
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiabilitiesAndOther
72000000 usd
disca Right Of Use Asset Obtained In Exchange For Finance Lease Liabilities And Other
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiabilitiesAndOther
27000000 usd
disca Noncash Or Part Noncash Assets Held For Sale
NoncashOrPartNoncashAssetsHeldForSale
25000000 usd
disca Noncash Or Part Noncash Assets Held For Sale
NoncashOrPartNoncashAssetsHeldForSale
0 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3027000000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3731000000 usd
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
50000000 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
199000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3077000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1240000000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-3418000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2309000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2962000000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
4000000 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
3000000 usd
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
5000000 usd
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
6000000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
16000000 usd
CY2022Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
11000000 usd
CY2023Q2 us-gaap Revenues
Revenues
10358000000 usd
CY2022Q2 us-gaap Revenues
Revenues
9827000000 usd
us-gaap Revenues
Revenues
21058000000 usd
us-gaap Revenues
Revenues
12986000000 usd
CY2023Q2 disca Total Adjusted Ebitda
TotalAdjustedEBITDA
2149000000 usd
CY2022Q2 disca Total Adjusted Ebitda
TotalAdjustedEBITDA
1664000000 usd
disca Total Adjusted Ebitda
TotalAdjustedEBITDA
4760000000 usd
disca Total Adjusted Ebitda
TotalAdjustedEBITDA
2691000000 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
7000000 usd
us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
24000000 usd
us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
23000000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-260000000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-836000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-438000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-635000000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1480000000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4244000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2718000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3568000000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
27000000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-51000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-46000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
439000000 usd
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-22000000 usd
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-43000000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-59000000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-57000000 usd
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5000000 usd
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5000000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
574000000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
511000000 usd
us-gaap Interest Expense
InterestExpense
1145000000 usd
us-gaap Interest Expense
InterestExpense
664000000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-906000000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3639000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1463000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3286000000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1914000000 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2266000000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3972000000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2791000000 usd
CY2023Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
135000000 usd
CY2022Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
147000000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
241000000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
204000000 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
146000000 usd
CY2022Q2 us-gaap Restructuring Charges
RestructuringCharges
1033000000 usd
us-gaap Restructuring Charges
RestructuringCharges
241000000 usd
us-gaap Restructuring Charges
RestructuringCharges
1038000000 usd
CY2023Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
47000000 usd
CY2022Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
983000000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
94000000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1070000000 usd
CY2023Q2 us-gaap Other Restructuring Costs
OtherRestructuringCosts
23000000 usd
CY2022Q2 us-gaap Other Restructuring Costs
OtherRestructuringCosts
0 usd
us-gaap Other Restructuring Costs
OtherRestructuringCosts
23000000 usd
us-gaap Other Restructuring Costs
OtherRestructuringCosts
0 usd
CY2023Q2 disca Business Combination Step Acquisition Equity Interest In Acquiree Fair Value Amortization
BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueAmortization
762000000 usd
CY2022Q2 disca Business Combination Step Acquisition Equity Interest In Acquiree Fair Value Amortization
BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueAmortization
870000000 usd
disca Business Combination Step Acquisition Equity Interest In Acquiree Fair Value Amortization
BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueAmortization
1593000000 usd
disca Business Combination Step Acquisition Equity Interest In Acquiree Fair Value Amortization
BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueAmortization
870000000 usd
CY2023Q2 disca Film Monetized On Its Own And In Film Group Amortization Of Interest
FilmMonetizedOnItsOwnAndInFilmGroupAmortizationOfInterest
22000000 usd
CY2022Q2 disca Film Monetized On Its Own And In Film Group Amortization Of Interest
FilmMonetizedOnItsOwnAndInFilmGroupAmortizationOfInterest
0 usd
disca Film Monetized On Its Own And In Film Group Amortization Of Interest
FilmMonetizedOnItsOwnAndInFilmGroupAmortizationOfInterest
22000000 usd
disca Film Monetized On Its Own And In Film Group Amortization Of Interest
FilmMonetizedOnItsOwnAndInFilmGroupAmortizationOfInterest
0 usd
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
6000000 usd
CY2022Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
4000000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
37000000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
4000000 usd
CY2023Q2 disca Total Adjusted Ebitda
TotalAdjustedEBITDA
2149000000 usd
CY2022Q2 disca Total Adjusted Ebitda
TotalAdjustedEBITDA
1664000000 usd
disca Total Adjusted Ebitda
TotalAdjustedEBITDA
4760000000 usd
disca Total Adjusted Ebitda
TotalAdjustedEBITDA
2691000000 usd

Files In Submission

Name View Source Status
0001437107-23-000144-index-headers.html Edgar Link pending
0001437107-23-000144-index.html Edgar Link pending
0001437107-23-000144.txt Edgar Link pending
0001437107-23-000144-xbrl.zip Edgar Link pending
a20230630-ex22tableofsenio.htm Edgar Link pending
a20230630-exhibit311.htm Edgar Link pending
a20230630-exhibit312.htm Edgar Link pending
a20230630-exhibit321.htm Edgar Link pending
a20230630-exhibit322.htm Edgar Link pending
a2023630-ex101amendmentn.htm Edgar Link pending
a2023630-ex101amendmentn001.jpg Edgar Link pending
a2023630-ex101amendmentn002.jpg Edgar Link pending
a2023630-ex101amendmentn003.jpg Edgar Link pending
a2023630-ex101amendmentn004.jpg Edgar Link pending
a2023630-ex101amendmentn005.jpg Edgar Link pending
a2023630-ex101amendmentn006.jpg Edgar Link pending
a2023630-ex101amendmentn007.jpg Edgar Link pending
a2023630-ex101amendmentn008.jpg Edgar Link pending
a2023630-ex101amendmentn009.jpg Edgar Link pending
a2023630-ex101amendmentn010.jpg Edgar Link pending
a2023630-ex101amendmentn011.jpg Edgar Link pending
a2023630-ex101amendmentn012.jpg Edgar Link pending
a2023630-ex101amendmentn013.jpg Edgar Link pending
a2023630-ex101amendmentn014.jpg Edgar Link pending
a2023630-ex101amendmentn015.jpg Edgar Link pending
a2023630-ex101amendmentn016.jpg Edgar Link pending
a2023630-ex101amendmentn017.jpg Edgar Link pending
a2023630-ex101amendmentn018.jpg Edgar Link pending
a2023630-ex101amendmentn019.jpg Edgar Link pending
a2023630-ex101amendmentn020.jpg Edgar Link pending
a2023630-ex101amendmentn021.jpg Edgar Link pending
a2023630-ex101amendmentn022.jpg Edgar Link pending
a2023630-ex101amendmentn023.jpg Edgar Link pending
a2023630-ex101amendmentn024.jpg Edgar Link pending
a2023630-ex101amendmentn025.jpg Edgar Link pending
a2023630-ex101amendmentn026.jpg Edgar Link pending
a2023630-ex101amendmentn027.jpg Edgar Link pending
a2023630-ex101amendmentn028.jpg Edgar Link pending
a2023630-ex101amendmentn029.jpg Edgar Link pending
a2023630-ex101amendmentn030.jpg Edgar Link pending
a2023630-ex101amendmentn031.jpg Edgar Link pending
a2023630-ex101amendmentn032.jpg Edgar Link pending
a2023630-ex101amendmentn033.jpg Edgar Link pending
a2023630-ex101amendmentn034.jpg Edgar Link pending
a2023630-ex101amendmentn035.jpg Edgar Link pending
a2023630-ex101amendmentn036.jpg Edgar Link pending
a2023630-ex101amendmentn037.jpg Edgar Link pending
a2023630-ex101amendmentn038.jpg Edgar Link pending
a2023630-ex101amendmentn039.jpg Edgar Link pending
a2023630-ex101amendmentn040.jpg Edgar Link pending
a2023630-ex101amendmentn041.jpg Edgar Link pending
a2023630-ex101amendmentn042.jpg Edgar Link pending
a2023630-ex101amendmentn043.jpg Edgar Link pending
a2023630-ex101amendmentn044.jpg Edgar Link pending
a2023630-ex101amendmentn045.jpg Edgar Link pending
a2023630-ex101amendmentn046.jpg Edgar Link pending
a2023630-ex101amendmentn047.jpg Edgar Link pending
a2023630-ex101amendmentn048.jpg Edgar Link pending
a2023630-ex101amendmentn049.jpg Edgar Link pending
a2023630-ex101amendmentn050.jpg Edgar Link pending
a2023630-ex101amendmentn051.jpg Edgar Link pending
a2023630-ex101amendmentn052.jpg Edgar Link pending
a2023630-ex101amendmentn053.jpg Edgar Link pending
a2023630-ex101amendmentn054.jpg Edgar Link pending
a2023630-ex101amendmentn055.jpg Edgar Link pending
a2023630-ex101amendmentn056.jpg Edgar Link pending
a2023630-ex101amendmentn057.jpg Edgar Link pending
a2023630-ex101amendmentn058.jpg Edgar Link pending
a2023630-ex101amendmentn059.jpg Edgar Link pending
a2023630-ex101amendmentn060.jpg Edgar Link pending
a2023630-ex101amendmentn061.jpg Edgar Link pending
a2023630-ex101amendmentn062.jpg Edgar Link pending
a2023630-ex101amendmentn063.jpg Edgar Link pending
a2023630-ex101amendmentn064.jpg Edgar Link pending
a2023630-ex101amendmentn065.jpg Edgar Link pending
a2023630-ex101amendmentn066.jpg Edgar Link pending
a2023630-ex101amendmentn067.jpg Edgar Link pending
a2023630-ex101amendmentn068.jpg Edgar Link pending
a2023630-ex101amendmentn069.jpg Edgar Link pending
a2023630-ex101amendmentn070.jpg Edgar Link pending
a2023630-ex101amendmentn071.jpg Edgar Link pending
a2023630-ex101amendmentn072.jpg Edgar Link pending
a2023630-ex101amendmentn073.jpg Edgar Link pending
a2023630-ex101amendmentn074.jpg Edgar Link pending
a2023630-ex101amendmentn075.jpg Edgar Link pending
a2023630-ex101amendmentn076.jpg Edgar Link pending
a2023630-ex101amendmentn077.jpg Edgar Link pending
a2023630-ex101amendmentn078.jpg Edgar Link pending
a2023630-ex101amendmentn079.jpg Edgar Link pending
a2023630-ex101amendmentn080.jpg Edgar Link pending
a2023630-ex101amendmentn081.jpg Edgar Link pending
a2023630-ex101amendmentn082.jpg Edgar Link pending
a2023630-ex101amendmentn083.jpg Edgar Link pending
a2023630-ex101amendmentn084.jpg Edgar Link pending
a2023630-ex101amendmentn085.jpg Edgar Link pending
a2023630-ex101amendmentn086.jpg Edgar Link pending
a2023630-ex101amendmentn087.jpg Edgar Link pending
a2023630-ex101amendmentn088.jpg Edgar Link pending
a2023630-ex101amendmentn089.jpg Edgar Link pending
a2023630-ex101amendmentn090.jpg Edgar Link pending
a2023630-ex101amendmentn091.jpg Edgar Link pending
a2023630-ex101amendmentn092.jpg Edgar Link pending
a2023630-ex101amendmentn093.jpg Edgar Link pending
a2023630-ex101amendmentn094.jpg Edgar Link pending
a2023630-ex101amendmentn095.jpg Edgar Link pending
a2023630-ex101amendmentn096.jpg Edgar Link pending
a2023630-ex101amendmentn097.jpg Edgar Link pending
a2023630-ex101amendmentn098.jpg Edgar Link pending
a2023630-ex101amendmentn099.jpg Edgar Link pending
a2023630-ex101amendmentn100.jpg Edgar Link pending
a2023630-ex101amendmentn101.jpg Edgar Link pending
a2023630-ex101amendmentn102.jpg Edgar Link pending
a2023630-ex101amendmentn103.jpg Edgar Link pending
a2023630-ex101amendmentn104.jpg Edgar Link pending
a2023630-ex101amendmentn105.jpg Edgar Link pending
a2023630-ex101amendmentn106.jpg Edgar Link pending
a2023630-ex101amendmentn107.jpg Edgar Link pending
a2023630-ex101amendmentn108.jpg Edgar Link pending
a2023630-ex101amendmentn109.jpg Edgar Link pending
a2023630-ex101amendmentn110.jpg Edgar Link pending
a2023630-ex101amendmentn111.jpg Edgar Link pending
a2023630-ex101amendmentn112.jpg Edgar Link pending
a2023630-ex101amendmentn113.jpg Edgar Link pending
a2023630-ex101amendmentn114.jpg Edgar Link pending
a2023630-ex101amendmentn115.jpg Edgar Link pending
a2023630-ex101amendmentn116.jpg Edgar Link pending
a2023630-ex101amendmentn117.jpg Edgar Link pending
a2023630-ex101amendmentn118.jpg Edgar Link pending
a2023630-ex101amendmentn119.jpg Edgar Link pending
a2023630-ex101amendmentn120.jpg Edgar Link pending
a2023630-ex101amendmentn121.jpg Edgar Link pending
a2023630-ex101amendmentn122.jpg Edgar Link pending
a2023630-ex101amendmentn123.jpg Edgar Link pending
a2023630-ex101amendmentn124.jpg Edgar Link pending
a2023630-ex101amendmentn125.jpg Edgar Link pending
a2023630-ex101amendmentn126.jpg Edgar Link pending
a2023630-ex101amendmentn127.jpg Edgar Link pending
a2023630-ex101amendmentn128.jpg Edgar Link pending
a2023630-ex101amendmentn129.jpg Edgar Link pending
a2023630-ex101amendmentn130.jpg Edgar Link pending
a2023630-ex101amendmentn131.jpg Edgar Link pending
a2023630-ex101amendmentn132.jpg Edgar Link pending
a2023630-ex102amendmentn.htm Edgar Link pending
a2023630-ex102amendmentn001.jpg Edgar Link pending
a2023630-ex102amendmentn002.jpg Edgar Link pending
a2023630-ex102amendmentn003.jpg Edgar Link pending
a2023630-ex102amendmentn004.jpg Edgar Link pending
a2023630-ex102amendmentn005.jpg Edgar Link pending
a2023630-ex102amendmentn006.jpg Edgar Link pending
a2023630-ex102amendmentn007.jpg Edgar Link pending
a2023630-ex102amendmentn008.jpg Edgar Link pending
a2023630-ex102amendmentn009.jpg Edgar Link pending
a2023630-ex102amendmentn010.jpg Edgar Link pending
a2023630-ex102amendmentn011.jpg Edgar Link pending
a2023630-ex102amendmentn012.jpg Edgar Link pending
a2023630-ex102amendmentn013.jpg Edgar Link pending
a2023630-ex102amendmentn014.jpg Edgar Link pending
a2023630-ex102amendmentn015.jpg Edgar Link pending
a2023630-ex102amendmentn016.jpg Edgar Link pending
a2023630-ex102amendmentn017.jpg Edgar Link pending
a2023630-ex102amendmentn018.jpg Edgar Link pending
a2023630-ex102amendmentn019.jpg Edgar Link pending
a2023630-ex102amendmentn020.jpg Edgar Link pending
a2023630-ex102amendmentn021.jpg Edgar Link pending
a2023630-ex102amendmentn022.jpg Edgar Link pending
a2023630-ex102amendmentn023.jpg Edgar Link pending
a2023630-ex102amendmentn024.jpg Edgar Link pending
a2023630-ex102amendmentn025.jpg Edgar Link pending
a2023630-ex102amendmentn026.jpg Edgar Link pending
a2023630-ex102amendmentn027.jpg Edgar Link pending
a2023630-ex102amendmentn028.jpg Edgar Link pending
a2023630-ex102amendmentn029.jpg Edgar Link pending
a2023630-ex102amendmentn030.jpg Edgar Link pending
a2023630-ex102amendmentn031.jpg Edgar Link pending
a2023630-ex102amendmentn032.jpg Edgar Link pending
a2023630-ex102amendmentn033.jpg Edgar Link pending
a2023630-ex102amendmentn034.jpg Edgar Link pending
a2023630-ex102amendmentn035.jpg Edgar Link pending
a2023630-ex102amendmentn036.jpg Edgar Link pending
a2023630-ex102amendmentn037.jpg Edgar Link pending
a2023630-ex102amendmentn038.jpg Edgar Link pending
a2023630-ex102amendmentn039.jpg Edgar Link pending
a2023630-ex102amendmentn040.jpg Edgar Link pending
a2023630-ex102amendmentn041.jpg Edgar Link pending
a2023630-ex102amendmentn042.jpg Edgar Link pending
a2023630-ex102amendmentn043.jpg Edgar Link pending
a2023630-ex102amendmentn044.jpg Edgar Link pending
a2023630-ex102amendmentn045.jpg Edgar Link pending
a2023630-ex102amendmentn046.jpg Edgar Link pending
a2023630-ex102amendmentn047.jpg Edgar Link pending
a2023630-ex102amendmentn048.jpg Edgar Link pending
a2023630-ex102amendmentn049.jpg Edgar Link pending
a2023630-ex102amendmentn050.jpg Edgar Link pending
a2023630-ex102amendmentn051.jpg Edgar Link pending
a2023630-ex102amendmentn052.jpg Edgar Link pending
a2023630-ex102amendmentn053.jpg Edgar Link pending
a2023630-ex102amendmentn054.jpg Edgar Link pending
a2023630-ex102amendmentn055.jpg Edgar Link pending
a2023630-ex102amendmentn056.jpg Edgar Link pending
a2023630-ex102amendmentn057.jpg Edgar Link pending
a2023630-ex102amendmentn058.jpg Edgar Link pending
a2023630-ex102amendmentn059.jpg Edgar Link pending
a2023630-ex102amendmentn060.jpg Edgar Link pending
a2023630-ex102amendmentn061.jpg Edgar Link pending
a2023630-ex102amendmentn062.jpg Edgar Link pending
a2023630-ex102amendmentn063.jpg Edgar Link pending
a2023630-ex102amendmentn064.jpg Edgar Link pending
a2023630-ex102amendmentn065.jpg Edgar Link pending
a2023630-ex102amendmentn066.jpg Edgar Link pending
a2023630-ex102amendmentn067.jpg Edgar Link pending
a2023630-ex102amendmentn068.jpg Edgar Link pending
a2023630-ex102amendmentn069.jpg Edgar Link pending
a2023630-ex102amendmentn070.jpg Edgar Link pending
a2023630-ex102amendmentn071.jpg Edgar Link pending
a2023630-ex102amendmentn072.jpg Edgar Link pending
a2023630-ex102amendmentn073.jpg Edgar Link pending
a2023630-ex102amendmentn074.jpg Edgar Link pending
a2023630-ex102amendmentn075.jpg Edgar Link pending
a2023630-ex102amendmentn076.jpg Edgar Link pending
a2023630-ex102amendmentn077.jpg Edgar Link pending
a2023630-ex102amendmentn078.jpg Edgar Link pending
a2023630-ex102amendmentn079.jpg Edgar Link pending
a2023630-ex102amendmentn080.jpg Edgar Link pending
a2023630-ex102amendmentn081.jpg Edgar Link pending
a2023630-ex102amendmentn082.jpg Edgar Link pending
a2023630-ex102amendmentn083.jpg Edgar Link pending
a2023630-ex102amendmentn084.jpg Edgar Link pending
a2023630-ex102amendmentn085.jpg Edgar Link pending
a2023630-ex102amendmentn086.jpg Edgar Link pending
a2023630-ex102amendmentn087.jpg Edgar Link pending
a2023630-ex102amendmentn088.jpg Edgar Link pending
a2023630-ex102amendmentn089.jpg Edgar Link pending
a2023630-ex102amendmentn090.jpg Edgar Link pending
a2023630-ex102amendmentn091.jpg Edgar Link pending
a2023630-ex102amendmentn092.jpg Edgar Link pending
a2023630-ex102amendmentn093.jpg Edgar Link pending
a2023630-ex102amendmentn094.jpg Edgar Link pending
a2023630-ex102amendmentn095.jpg Edgar Link pending
a2023630-ex102amendmentn096.jpg Edgar Link pending
a2023630-ex102amendmentn097.jpg Edgar Link pending
a2023630-ex102amendmentn098.jpg Edgar Link pending
a2023630-ex102amendmentn099.jpg Edgar Link pending
a2023630-ex102amendmentn100.jpg Edgar Link pending
a2023630-ex102amendmentn101.jpg Edgar Link pending
a2023630-ex102amendmentn102.jpg Edgar Link pending
a2023630-ex102amendmentn103.jpg Edgar Link pending
a2023630-ex102amendmentn104.jpg Edgar Link pending
a2023630-ex102amendmentn105.jpg Edgar Link pending
a2023630-ex102amendmentn106.jpg Edgar Link pending
a2023630-ex102amendmentn107.jpg Edgar Link pending
a2023630-ex102amendmentn108.jpg Edgar Link pending
a2023630-ex102amendmentn109.jpg Edgar Link pending
a2023630-ex102amendmentn110.jpg Edgar Link pending
a2023630-ex102amendmentn111.jpg Edgar Link pending
a2023630-ex102amendmentn112.jpg Edgar Link pending
a2023630-ex102amendmentn113.jpg Edgar Link pending
a2023630-ex102amendmentn114.jpg Edgar Link pending
a2023630-ex102amendmentn115.jpg Edgar Link pending
a2023630-ex102amendmentn116.jpg Edgar Link pending
a2023630-ex102amendmentn117.jpg Edgar Link pending
a2023630-ex102amendmentn118.jpg Edgar Link pending
a2023630-ex102amendmentn119.jpg Edgar Link pending
a2023630-ex102amendmentn120.jpg Edgar Link pending
a2023630-ex102amendmentn121.jpg Edgar Link pending
a2023630-ex102amendmentn122.jpg Edgar Link pending
a2023630-ex102amendmentn123.jpg Edgar Link pending
a2023630-ex102amendmentn124.jpg Edgar Link pending
a2023630-ex102amendmentn125.jpg Edgar Link pending
a2023630-ex102amendmentn126.jpg Edgar Link pending
a2023630-ex102amendmentn127.jpg Edgar Link pending
a2023630-ex102amendmentn128.jpg Edgar Link pending
a2023630-ex102amendmentn129.jpg Edgar Link pending
a2023630-ex102amendmentn130.jpg Edgar Link pending
a2023630-ex102amendmentn131.jpg Edgar Link pending
a2023630-ex102amendmentn132.jpg Edgar Link pending
a2023630-ex102amendmentn133.jpg Edgar Link pending
a2023630-ex102amendmentn134.jpg Edgar Link pending
a2023630-ex102amendmentn135.jpg Edgar Link pending
a2023630-ex102amendmentn136.jpg Edgar Link pending
a2023630-ex102amendmentn137.jpg Edgar Link pending
a2023630-ex102amendmentn138.jpg Edgar Link pending
a2023630-ex102amendmentn139.jpg Edgar Link pending
a2023630-ex102amendmentn140.jpg Edgar Link pending
a2023630-ex102amendmentn141.jpg Edgar Link pending
a2023630-ex102amendmentn142.jpg Edgar Link pending
a2023630-ex102amendmentn143.jpg Edgar Link pending
a2023630-ex102amendmentn144.jpg Edgar Link pending
a2023630-ex102amendmentn145.jpg Edgar Link pending
a2023630-ex102amendmentn146.jpg Edgar Link pending
a2023630-ex102amendmentn147.jpg Edgar Link pending
a2023630-ex102amendmentn148.jpg Edgar Link pending
a2023630-ex102amendmentn149.jpg Edgar Link pending
a2023630-ex102amendmentn150.jpg Edgar Link pending
a2023630-ex102amendmentn151.jpg Edgar Link pending
a2023630-ex102amendmentn152.jpg Edgar Link pending
a2023630-ex102amendmentn153.jpg Edgar Link pending
a2023630-ex102amendmentn154.jpg Edgar Link pending
a2023630-ex102amendmentn155.jpg Edgar Link pending
a2023630-ex102amendmentn156.jpg Edgar Link pending
a2023630-ex102amendmentn157.jpg Edgar Link pending
a2023630-ex102amendmentn158.jpg Edgar Link pending
a2023630-ex102amendmentn159.jpg Edgar Link pending
a2023630-ex102amendmentn160.jpg Edgar Link pending
a2023630-ex102amendmentn161.jpg Edgar Link pending
a2023630-ex102amendmentn162.jpg Edgar Link pending
a2023630-ex102amendmentn163.jpg Edgar Link pending
a2023630-ex102amendmentn164.jpg Edgar Link pending
a2023630-ex102amendmentn165.jpg Edgar Link pending
a2023630-ex102amendmentn166.jpg Edgar Link pending
a2023630-ex102amendmentn167.jpg Edgar Link pending
a2023630-ex102amendmentn168.jpg Edgar Link pending
a2023630-ex102amendmentn169.jpg Edgar Link pending
a2023630-ex102amendmentn170.jpg Edgar Link pending
a2023630-ex102amendmentn171.jpg Edgar Link pending
a2023630-ex102amendmentn172.jpg Edgar Link pending
a2023630-ex102amendmentn173.jpg Edgar Link pending
a2023630-ex102amendmentn174.jpg Edgar Link pending
a2023630-ex102amendmentn175.jpg Edgar Link pending
a2023630-ex102amendmentn176.jpg Edgar Link pending
a2023630-ex102amendmentn177.jpg Edgar Link pending
a2023630-ex102amendmentn178.jpg Edgar Link pending
a2023630-ex102amendmentn179.jpg Edgar Link pending
a2023630-ex102amendmentn180.jpg Edgar Link pending
a2023630-ex102amendmentn181.jpg Edgar Link pending
a2023630-ex102amendmentn182.jpg Edgar Link pending
a2023630-ex102amendmentn183.jpg Edgar Link pending
a2023630-ex102amendmentn184.jpg Edgar Link pending
a2023630-ex102amendmentn185.jpg Edgar Link pending
a2023630-ex102amendmentn186.jpg Edgar Link pending
a2023630-ex102amendmentn187.jpg Edgar Link pending
a2023630-ex102amendmentn188.jpg Edgar Link pending
a2023630-ex102amendmentn189.jpg Edgar Link pending
a2023630-ex102amendmentn190.jpg Edgar Link pending
a2023630-ex102amendmentn191.jpg Edgar Link pending
a2023630-ex102amendmentn192.jpg Edgar Link pending
a2023630-ex102amendmentn193.jpg Edgar Link pending
a2023630-ex102amendmentn194.jpg Edgar Link pending
a2023630-ex102amendmentn195.jpg Edgar Link pending
a2023630-ex102amendmentn196.jpg Edgar Link pending
a2023630-ex102amendmentn197.jpg Edgar Link pending
a2023630-ex102amendmentn198.jpg Edgar Link pending
a2023630-ex102amendmentn199.jpg Edgar Link pending
a2023630-ex102amendmentn200.jpg Edgar Link pending
a2023630-ex102amendmentn201.jpg Edgar Link pending
a2023630-ex102amendmentn202.jpg Edgar Link pending
a2023630-ex102amendmentn203.jpg Edgar Link pending
a2023630-ex102amendmentn204.jpg Edgar Link pending
a2023630-ex102amendmentn205.jpg Edgar Link pending
disca-20230630.htm Edgar Link pending
disca-20230630.xsd Edgar Link pending
disca-20230630_g1.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
disca-20230630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
disca-20230630_pre.xml Edgar Link unprocessable
disca-20230630_htm.xml Edgar Link completed
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
disca-20230630_cal.xml Edgar Link unprocessable
disca-20230630_lab.xml Edgar Link unprocessable